Comparative Pharmacology
Head-to-head clinical analysis: OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN versus WESTADONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN versus WESTADONE.
OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN vs WESTADONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Oxycodone is a mu-opioid receptor agonist, inhibiting neurotransmitter release and pain signal transmission. Acetaminophen inhibits cyclooxygenase (COX) enzymes, particularly in the central nervous system, reducing prostaglandin synthesis and pain perception.
Mu-opioid receptor agonist; also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake.
Adults: 1-2 tablets (each containing 5 mg oxycodone/325 mg acetaminophen) orally every 4-6 hours as needed for pain; maximum 12 tablets per day (60 mg oxycodone/3900 mg acetaminophen).
Oral: 2.5-10 mg every 4-6 hours as needed for pain; maximum 40 mg per day.
None Documented
None Documented
Oxycodone: 3.5-5.5 hours (immediate-release); Acetaminophen: 1.5-3 hours. Clinical context: renal/hepatic impairment prolongs half-life.
Terminal elimination half-life: 15-60 hours (mean ~24 hours). Clinical context: Prolonged half-life supports once-daily dosing in opioid maintenance; accumulation occurs with repeated dosing due to long half-life.
Oxycodone: primarily renal (10-20% unchanged, metabolites conjugated); Acetaminophen: renal (85-90%, primarily as glucuronide and sulfate conjugates, <5% unchanged).
Primarily renal (40-50% as unchanged methadone and its metabolites, 15-20% as metadone-N-oxide), biliary/fecal (5-10%).
Category D/X
Category C
Opioid Agonist
Opioid Agonist